ARTICLE | Clinical News
Adnexus preclinical data
August 27, 2007 7:00 AM UTC
In animals, CT-322 inhibited tumor growth and reduced metastases compared with controls. The protein therapeutic that inhibits vascular endothelial growth factor (VEGF) receptor 2 ( KDR/Flk-1) also d...